NTI164: Clinical Trials

6 trials of NTI164, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 not yet recruiting. 4 Phase 2, 3 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Not yet recruiting 1
Phase 13Completed 3
Phase 33Not yet recruiting 2, Completed 1

Follow NTI164: new trials by email Literature Review of NTI164 trials Research Report on NTI164

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome
NTI164, Placebo - RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome
Phase 2 / Phase 3Not yet recruitingFenix Innovation Group402027-07-012026-09-09
NTI164 in Autism Spectrum Disorder
NTI164, Placebo - Autism, Autism Spectrum Disorder
Phase 3Not yet recruitingFenix Innovation Group2002026-09-302026-09-30
NTI164 Human PK Study
NTI164 - Healthy, Healthy Volunteer
Phase 1CompletedFenix Innovation Group122024-02-012026-09-09
Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT)
NTI164 - Rett Syndrome
Phase 1 / Phase 2CompletedFenix Innovation Group142023-09-202026-09-09
Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS)
NTI164 - PANS Pediatric Acute-Onset Neuropsychiatric Syndrome
Phase 1 / Phase 2CompletedFenix Innovation Group182023-06-022026-09-09
Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder
NTI164 - Autism Spectrum Disorder
Phase 2 / Phase 3CompletedFenix Innovation Group542022-11-302026-09-10

Conditions studied

Marijuana Abuse (3)  ·  Autism Spectrum Disorder (2)  ·  Rett Syndrome (2)  ·  Autistic Disorder (1)  ·  Pediatric acute-onset neuropsychiatric syndrome (1)

Sponsors

Fenix Innovation Group (6)

Countries

Australia (6)

Top investigators

Michael Fahey, Prof (1)